News by subject: HEALTH

Algernon Pharmaceuticals Inc.  (the "Company" or "Algernon") a Canadian clinical stage pharmaceutical development company announces the close of its non-brokered private placement, previously announced on December 12, 2023 and updated on December...

It was a year of fast and furious activity for Bow Valley College. Did you blink? Then, you may have missed some of the excitement. Join us for a trip back in time as we look at the greatest Bow Valley College moments and stories of 2023.  The...

We are thrilled to announce that Charles Brown, the President and CEO of LifeLabs, has been honoured with the prestigious Leadership Excellence in Medical Diagnostics and Laboratory Testing in the 2023 CEO Healthcare Awards, presented by CEO Today...

December 19, 2023Amsterdam, the Netherlands ? Royal Philips  today announced that it has completed the cancellation of 15,134,054 of its shares. The cancelled shares were acquired as part of the EUR 1.5 billion share repurchase program for capital...

Proceeds will support lead precision oncology program into the clinic and advance earlier stage pipelineAtavistik Bio is discovering transformative precision allosteric small molecule therapeutics for genetically validated targets by leveraging the...

Lantheus Holdings, Inc. (Lantheus) and POINT Biopharma Global Inc. (POINT) today announced statistically significant topline results from the pivotal phase 3 SPLASH study evaluating the efficacy and safety of 177Lu-PNT2002, a prostate-specific...

Extendicare Inc. ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of December 2023, which is payable on January 15, 2024 to shareholders of...

Biogen Inc. announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended marketing authorization for SKYCLARYS® (omaveloxolone) for the...

The holidays are not so merry and bright for millions of people in Canada. Holiday depression and anxiety, along with loneliness, can mean trying days for so many at this time of year. Ontario Shores Centre for Mental Health Sciences (Ontario...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces a collaboration with Seegene USA, Inc. ("Seegene USA"), a leading developer of multiplex molecular assays and automated solutions for U.S. labs. Under the...

Biogen Inc. and Sage...

Updated label means new Trogarzo® patients no longer require initiation of treatment by 30-minute infusionComplete IV push method enables easier and more convenient administration of Trogarzo® for heavily treatment-experienced adults with HIV This...

Arch Biopartners Inc., ("Arch" or the "Company") , announced today it has submitted a Clinical Trial Application to Health Canada to obtain permission to proceed with a Phase II trial for LSALT peptide, targeting the prevention and treatment of...

Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has...

Algernon Pharmaceuticals Inc.  (the "Company" or "Algernon") a Canadian clinical stage pharmaceutical development company announces a non-brokered private placement for gross proceeds of $150,000 (the "Offering") of units (the "Units") at an issue...

Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announces that it has accepted...

After today's announcement that eligible seniors will be invited to apply for enrollment in the Canadian Dental Care Plan (CDCP) starting this month, and care could begin as early as May 2024, many questions remain. It is unclear how this new program...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for...

London, UK ? December 11, 2023 ? OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is excited to announce a strategic collaboration with Nested...

Optimi Health Corp. (FRA: 8BN) ("Optimi"), a licensed Canadian drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, today announced the signing of a supply agreement with Sunshine...

LifeLabs, Canada's leading provider of medical diagnostic services, is proud to unveil the 2022 Community Report titled "Committed to Care." This report highlights the incredible journey of our dedicated team over the past year, exemplifying our...

Thornhill Medical announced today that it is participating in a pilot project which aims to increase medical surge capabilities and capacity of the U.S. National Disaster Medical System (NDMS). Funded by the Defense Health Agency (DHA), the pilot...

Moleac announced promising results from the SAMURAI double-blind study in patients with mild traumatic brain injury (mTBI) receiving a 6-month course of NeuroAiDtmII. In the study, the NeuroAiDtmII group showed significant improvement in their...

Sunshine Biopharma, Inc. (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has moved its headquarters to New York...

Bahrain has become the second country in the world and the first in the Middle East to approve the use of CASGEVY (exagamglogene autotemcel) for the treatment of patients with sickle cell disease and transfusion-dependent beta-thalassemia. The...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the...

Zymeworks Inc. , a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: 42nd Annual J.P. Morgan Healthcare Conference: Zymeworks'...

King Faisal Specialist Hospital and Research Center takes great pride in recognizing the exceptional dedication of its diverse workforce, with each member contributing two decades to the noble mission of patient care. His Excellency, CEO Dr. Majid...

November 29, 2023 Amsterdam, the Netherlands and Chicago, USA ? Royal Philips a global leader in health technology, and Vanderbilt University Medical Center (VUMC), home to top-ranked adult and pediatric hospitals in the Southeastern U.S., today...

Assure Holdings Corp. (the "Company" or "Assure") , a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, today announced that on November 21, 2023 it received a notice (the "Notice") from the Nasdaq Stock Market LLC...

Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction...

On September 21, 2023 the 34th and final 65 Roses Ladies Golf Classic was held at The Winston Golf Club. This tournament was the longest running women-only tournament in Calgary and has raised over 1.25 million dollars in support of Cystic Fibrosis...

The Blinc Group, a pioneering force in the cannabis vaporizer industry, today announced a significant leadership transition. Pete Sahani, who has been serving as the Company's COO since 2022, has been appointed as CEO. Arnaud Dumas de Rauly,...

November 28, 2023 Amsterdam, the Netherlands and Chicago, USA ? Royal Philips , a global leader in health technology, today launched three new fit for purpose MR Smart Fit coils at #RSNA23. RF coils are an essential part of every MRI scan. The...

Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is providing this update on the status...

Ceapro Inc. ? ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active...

November 27, 2023 Amsterdam, the Netherlands and Chicago, USA ? Royal Philips , a global leader in health technology, today announced the expansion of its enterprise imaging portfolio and AI-enabled solutions at #RSNA23. Philips HealthSuite...

This holiday season, Pizza Nova will offer its 60th anniversary tote bag, featuring the brand's renowned "Ciao" greeting, to help raise funds for SickKids Foundation. Retailing at $15.99 per bag, Pizza Nova will donate a portion of proceeds toward...

November 27, 2023 Improved imaging and advanced tools drive standardized workflow efficiency across multiple specialtiesShared common interface and transducers let users move effortlessly between ultrasound systems for a more simplified user...

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today reported topline results from the randomized, double-blind, placebo-controlled, Phase 2 proof-of-concept X-NOVA clinical trial, which evaluated the clinical efficacy,...

November 26, 2023 BlueSeal MR Mobile's unique magnet technology advances patient outcomes and access to care with high quality diagnostic imaging and enhanced workflows Amsterdam, the Netherlands and Chicago, USA ? Royal Philips , a global...

November 26, 2023 New innovations help hospitals and health systems to consistently deliver accessible, high-quality care to patients in a sustainable way Amsterdam, the Netherlands and Chicago, USA ? Royal Philips , a global leader in...

Curium, a global leader in nuclear medicine, announced today the successful completion of patient enrollment in the pivotal Phase 3 ECLIPSE trial. ECLIPSE is a Phase 3, multi-center, open-label, randomized clinical trial comparing the safety and...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced a new publication...

bioLytical, in partnership with NGO Coalition PLUS, has donated over 8,000 rapid tests across 25 countries and partner organizationsbioLytical is a Canadian company that develops and manufactures all its tests locally for worldwide...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome's Chief Executive Officer, will...

Phase two of Economist Impact's Health Inclusivity Index, supported by Haleon, measures experience of health inclusion across 42,000 people in 40 countriesHealth inclusivity scores fall worldwide with addition of lived experience data, exposing...

The revelation that former Health Minister Christine Elliott has registered as a lobbyist for a for-profit hospital known as Don Mills Surgical Unit, now owned by Clearpoint Health Network, has raised serious questions about ethics and conflict of...

Every 20 seconds, an individual with diabetes loses a limb due to poor foot health. Each year, over 700 Albertans undergo diabetes-related lower-limb amputations. Sadly, 90% of these amputations are preventable. A long-time Calgary community...